The effect of soy isoflavones supplementation on metabolic status in patients with non-alcoholic fatty liver disease: a randomized placebo controlled clinical trial
- PMID: 38773414
- PMCID: PMC11107053
- DOI: 10.1186/s12889-024-18812-3
The effect of soy isoflavones supplementation on metabolic status in patients with non-alcoholic fatty liver disease: a randomized placebo controlled clinical trial
Abstract
Background: Non-alcoholic fatty liver disease (NAFLD) accounts as a crucial health concern with a huge burden on health and economic systems. The aim of this study is to evaluate the effect of soy isoflavones supplementation on metabolic status in patients with NAFLD.
Methods: In this randomized clinical trial, 50 patients with NAFLD were randomly allocated to either soy isoflavone or placebo groups for 12 weeks. The soy isoflavone group took 100 mg/d soy isoflavone and the placebo group took the similar tablets containing starch. Anthropometric indices, blood lipids, glycemic parameters and blood pressure were measured at the beginning and at the end of the study.
Results: At the end of week 12 the level of serum triglyceride (TG), low density lipoprotein (LDL) and total cholesterol (TC) was significantly decreased only in soy isoflavone group compared to baseline (P < 0.05). Although waist circumference (WC) decreased significantly in both groups after 12 weeks of intervention (P < 0.05), hip circumference (HC) decreased significantly only in soy isoflavone group (P = 0.001). No significant changes observed regarding high density lipoprotein (HDL) and blood pressure in both groups. At the end of the study, serum glucose level was significantly decreased in the placebo group compared to baseline (P = 0.047). No significant changes demonstrated in the soy isoflavone group in regard to glycemic parameters (P > 0.05).
Conclusions: This study revealed that soy isoflavones could significantly reduce TG, LDL TC, WC and HC in NAFLD patients.
Trial registration: The Ethics committee of Ahvaz Jundishapur University of Medical Sciences approved the protocol of the present clinical research (IR.AJUMS.REC.1401.155). The study was in accordance with the Declaration of Helsinki. This study's registered number and date are IRCT20220801055597N1 and 20.09.2022, respectively at https://fa.irct.ir .
Keywords: Isoflavone; Metabolic factors; Non-alcoholic fatty liver disease; Soy.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Similar articles
-
Hypolipidemic Effects of Soy Protein and Isoflavones in the Prevention of Non-Alcoholic Fatty Liver Disease- A Review.Plant Foods Hum Nutr. 2022 Sep;77(3):319-328. doi: 10.1007/s11130-022-00984-1. Epub 2022 Jun 9. Plant Foods Hum Nutr. 2022. PMID: 35678936 Free PMC article. Review.
-
Effects of soy isoflavones on serum lipids and lipoprotein (a) in peritoneal dialysis patients.Nutr Metab Cardiovasc Dis. 2020 Jul 24;30(8):1382-1388. doi: 10.1016/j.numecd.2020.04.023. Epub 2020 May 5. Nutr Metab Cardiovasc Dis. 2020. PMID: 32513581 Clinical Trial.
-
The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial.Trials. 2017 Jun 7;18(1):260. doi: 10.1186/s13063-017-1979-3. Trials. 2017. PMID: 28592311 Free PMC article. Clinical Trial.
-
Soy proteins and isoflavones reduce interleukin-6 but not serum lipids in older women: a randomized controlled trial.Nutr Res. 2013 Dec;33(12):1026-33. doi: 10.1016/j.nutres.2013.08.009. Epub 2013 Sep 18. Nutr Res. 2013. PMID: 24267042 Free PMC article. Clinical Trial.
-
Effects of soy isoflavone supplements on bone turnover markers in menopausal women: systematic review and meta-analysis of randomized controlled trials.Bone. 2010 Aug;47(2):413-23. doi: 10.1016/j.bone.2010.05.001. Epub 2010 May 7. Bone. 2010. PMID: 20452475 Review.
References
-
- Salehisahlabadi A, Sadat S, Lotfi A, Mohseni M, Jadidi H. Prevalence of non-alcoholic fatty liver disease in Iran: a population based study. Middle East J Dig Dis. 2010;2:14–9. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous